A detailed history of Jane Street Group, LLC transactions in Geron Corp stock. As of the latest transaction made, Jane Street Group, LLC holds 950,666 shares of GERN stock, worth $3.79 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
950,666
Previous 1,483,880 35.93%
Holding current value
$3.79 Million
Previous $6.29 Million 31.39%
% of portfolio
0.0%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.17 - $4.99 $2.22 Million - $2.66 Million
-533,214 Reduced 35.93%
950,666 $4.32 Million
Q2 2024

Aug 14, 2024

BUY
$3.1 - $5.09 $3.09 Million - $5.07 Million
995,375 Added 203.76%
1,483,880 $6.29 Million
Q1 2024

May 15, 2024

SELL
$1.75 - $3.44 $218,592 - $429,690
-124,910 Reduced 20.36%
488,505 $1.61 Million
Q4 2023

Feb 14, 2024

BUY
$1.74 - $2.31 $739,609 - $981,895
425,063 Added 225.67%
613,415 $1.29 Million
Q3 2023

Nov 14, 2023

SELL
$2.11 - $3.28 $810,989 - $1.26 Million
-384,355 Reduced 67.11%
188,352 $399,000
Q2 2023

Aug 14, 2023

BUY
$1.97 - $3.69 $574,217 - $1.08 Million
291,481 Added 103.65%
572,707 $1.84 Million
Q1 2023

May 15, 2023

BUY
$2.14 - $3.4 $534,178 - $848,694
249,616 Added 789.67%
281,226 $610,000
Q4 2022

Feb 14, 2023

SELL
$2.03 - $2.42 $30,506 - $36,367
-15,028 Reduced 32.22%
31,610 $76,000
Q3 2022

Nov 14, 2022

SELL
$1.67 - $2.94 $46,529 - $81,914
-27,862 Reduced 37.4%
46,638 $109,000
Q3 2022

Nov 14, 2022

SELL
$1.67 - $2.94 $46,529 - $81,914
-27,862 Reduced 37.4%
46,638 $109,000
Q2 2022

Aug 16, 2022

BUY
$1.19 - $1.65 $88,655 - $122,925
74,500 New
74,500 $115,000
Q1 2022

May 17, 2022

SELL
$0.99 - $1.6 $135,198 - $218,502
-136,564 Closed
0 $0
Q4 2021

Feb 15, 2022

BUY
$1.22 - $1.72 $120,576 - $169,992
98,833 Added 261.94%
136,564 $166,000
Q3 2021

Nov 16, 2021

SELL
$1.2 - $1.5 $90,267 - $112,834
-75,223 Reduced 66.6%
37,731 $52,000
Q2 2021

Aug 16, 2021

BUY
$1.25 - $1.83 $96,850 - $141,788
77,480 Added 218.41%
112,954 $159,000
Q1 2021

May 18, 2021

BUY
$1.52 - $2.1 $10,142 - $14,013
6,673 Added 23.17%
35,474 $57,000
Q4 2020

Feb 17, 2021

SELL
$1.55 - $2.05 $162,574 - $215,018
-104,887 Reduced 78.46%
28,801 $46,000
Q3 2020

Nov 17, 2020

BUY
$1.59 - $2.19 $178,103 - $245,312
112,015 Added 516.84%
133,688 $233,000
Q2 2020

Aug 17, 2020

BUY
$1.05 - $2.18 $22,756 - $47,247
21,673 New
21,673 $47,000
Q3 2019

Nov 14, 2019

SELL
$1.15 - $1.59 $57,945 - $80,115
-50,387 Closed
0 $0
Q2 2019

Aug 15, 2019

BUY
$1.37 - $2.02 $69,030 - $101,781
50,387 New
50,387 $71,000
Q1 2019

May 16, 2019

SELL
$1.01 - $1.83 $154,563 - $280,050
-153,033 Closed
0 $0
Q4 2018

Feb 15, 2019

BUY
$0.98 - $1.85 $32,543 - $61,434
33,208 Added 27.71%
153,033 $153,000
Q3 2018

Nov 14, 2018

BUY
$1.76 - $6.38 $184,205 - $667,743
104,662 Added 690.25%
119,825 $211,000
Q2 2018

Aug 15, 2018

SELL
$3.29 - $4.82 $105,095 - $153,970
-31,944 Reduced 67.81%
15,163 $52,000
Q1 2018

May 15, 2018

BUY
$1.81 - $5.98 $85,263 - $281,699
47,107 New
47,107 $200,000
Q4 2017

Feb 15, 2018

SELL
$1.8 - $2.32 $18,129 - $23,367
-10,072 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$1.99 - $2.65 $20,043 - $26,690
10,072
10,072 $22,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.51B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.